Page last updated: 2024-09-03

brl 44408 and rauwolscine

brl 44408 has been researched along with rauwolscine in 1 studies

Compound Research Comparison

Studies
(brl 44408)
Trials
(brl 44408)
Recent Studies (post-2010)
(brl 44408)
Studies
(rauwolscine)
Trials
(rauwolscine)
Recent Studies (post-2010) (rauwolscine)
8201647014

Protein Interaction Comparison

ProteinTaxonomybrl 44408 (IC50)rauwolscine (IC50)
Alpha-2C adrenergic receptorHomo sapiens (human)0.016
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.165
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.165
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.165

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neubig, RR; Porter, AC; Uhlén, S1

Other Studies

1 other study(ies) available for brl 44408 and rauwolscine

ArticleYear
The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; CHO Cells; Cricetinae; Dibenzazepines; Humans; Imidazoles; Indoles; Isoindoles; Quinolizines; Radioligand Assay; Receptors, Adrenergic, alpha-2

1994